Skip to content

Prescription patterns and pharmacological mechanisms of famous TCM doctors in treating ulcerative colitis study based on data mining and bioinformatics

Prescription patterns and pharmacological mechanisms of famous TCM doctors in treating ulcerative colitis study based on data mining and bioinformatics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001030
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

treatment group:Basic treatment combined with new prescription

Sponsors

Beijing Anorectal Hospital (Beijing Erlong Road Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) The age limit is 18-65 years old and the gender is not limited to ensure that the research objects have a certain representativeness and universality. (2) Western medicine diagnosed ulcerative colitis in line with UC active stage diagnosis criteria the first modified Mayo score between 3-10Mayo endoscopic score 1-2 points that is the disease is active stage and mild to moderate; The diagnosis of TCM is diarrhea and the type of syndrome is determined by the final selection of TCM compound. (3) The patient is in good physical and mental condition has no obvious abnormalities has complete basic information can fully understand the research content and voluntarily sign the informed consent actively cooperate with the whole process of clinical trial and strictly follow the clinical treatment standards to ensure the smooth progress of the study and the reliability of the data.

Exclusion criteria

Exclusion criteria: (1) those over the age range of 18-65 years; (2) Planning to get pregnant pregnant or lactating patients and patients with drug allergy history; (3) During the course of the disease the drug effect is not obvious or there are emergency complications such as gastrointestinal bleeding colorectal cancer and other patients who need surgical treatment; (4) Patients with heart liver kidney immune mental and other major underlying diseases; (5) Patients who need oral hormones or other drugs at the same time as clinical trials; (6) Patients who have been recruited for clinical trials of drugs in other groups.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;Dynamic erythrocyte sedimentation rate;

Secondary

MeasureTime frame
TCM syndrome score;Urinalysis;Modified Mayo score;Electrocardiography;

Countries

China

Contacts

Public ContactSu Yue

Beijing Anorectal Hospital (Beijing Erlong Road Hospital)

suyue20082626@163.com13683360311

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026